Comparative Study of SPSIPB vs Thoracic Paravertebral Block for Opioid Reduction
Positive results could lead to a shift in clinical guidelines favoring SPSIPB, affecting market dynamics for anesthetic techniques and opioid alternatives.
Phase III
Pain Management / Anesthesia
Status
Active
Sponsor
Pain Management
Signal Score
6.8
Signal assessment
Signal strength
moderate
Confidence level
moderate
Strategic implication
Positive results could lead to a shift in clinical guidelines favoring SPSIPB, affecting market dynamics for anesthetic techniques and opioid alternatives.
Why it matters
Positive results could lead to a shift in clinical guidelines favoring SPSIPB, affecting market dynamics for anesthetic techniques and opioid alternatives.
What changed
Trial Update
Analysis
This clinical trial aims to compare the analgesic efficacy of Serratus Posterior Superior Intercostal Plane Block and Thoracic Paravertebral Block in reducing postoperative opioid consumption after open thoracotomy.
Positive results could lead to a shift in clinical guidelines favoring SPSIPB, affecting market dynamics for anesthetic techniques and opioid alternatives.
Monitor the trial results for differences in opioid consumption and respiratory outcomes, as well as subsequent adoption in clinical practice.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.